NF1 and neurofibroma: In alignment with existing literature, our study found that patients with microdeletion syndrome exhibited a more severe clinical phenotype compared to individuals with intragenic NF1 mutations, highlighting the importance of thorough monitoring and follow-up using brain and whole-body MRI to assess for intracranial manifestations, neurofibromas, and potential malignancies.